You are currently accessing this Site as a guest. Please login or register by clicking Here
NoBlood - Through Transfusion Alternatives and Blood Management

NoBlood

Through Transfusion Alternatives
and Blood Management

Click here to see who are advancing transfusion alternatives and blood management.
Click here and see who are advancing transfusion alternatives and blood management.

Go Back   NoBlood > Resources > Medical Articles and Abstracts

The impact of weekly dosing of epoetin alfa on the haematological parameters and on t The impact of weekly dosing of epoetin alfa on the haematological parameters and on t



Welcome to NoBlood.

You are currently accessing this Site as a guest which gives you limited access to most discussions and other features. By registering you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, register today!

If you have any problems with the registration process or your account login, please contact contact us. If you forgot your password, click here to request a new one.

Tags: , , ,

Reply
 
LinkBack Thread Tools Rate Thread Display Modes
  #1 (permalink)  
Old 04-27-2005, 07:13 PM
Nika's Avatar
Registered User
  
Join Date: Mar 2005
Posts: 199
Thanks: 0
Thanked 4 Times in 4 Posts
Nika is on a distinguished road
The impact of weekly dosing of epoetin alfa on the haematological parameters and on t
Source:
Eur J Cancer Care (Engl). 2005 May;14(2):108-12

The impact of weekly dosing of epoetin alfa on the haematological parameters and on the quality of life of anaemic cancer patients.

Heras P, Argyriou AA, Papapetropoulos S, Karagiannis S, Argyriou K, Mitsibounas D.

Division of Clinical Oncology, Department of Medicine, General Hospital of Kos Island, Greece.

HERAS P., ARGYRIOU A.A., PAPAPETROPOULOS S., KARAGIANNIS S., ARGYRIOU K. & MITSIBOUNAS D. (2005) European Journal of Cancer Care14, 108-112 The impact of weekly dosing of epoetin alfa on the haematological parameters and on the quality of life of anaemic cancer patients The aim of this study was to evaluate the effectiveness and the impact of once-weekly administration of epoetin alfa (Ea) on the management of anaemia and on the quality of life (QOL) of cancer patients receiving chemotherapy. Eighty cancer patients with life expectancy >/= 24 weeks and haemoglobin (Hb) levels < 10.5 g/dL were studied. After an initial screening of patients' demographic and clinical characteristics, Ea 40000 U once a week was administered over a period of 4 months. In case of patients with Hb level exceeding > 14 g/dL or in case of non-response, the dosage was reconsidered. Every month, data regarding Hb levels, clinical variations, changes in the chemotherapy regimen and transfusion use since the last study visit, were evaluated. The Linear Analogue Scale Assessment scale was used for the evaluation of the QOL. The readmissions to hospital rates (P < 0.002) and the transfusion use rates (P < 0.003) were significantly decreased comparatively with baseline. A mean increase from baseline to the final Hb level (P < 0.001) was established, as well as a significant improvement in the functional ability, energy and in the overall QOL (P < 0.001). In conclusion, the treatment of cancer patients with Ea once-weekly is effective and safe, improving their haematological parameters and QOL.

PMID: 15842457 [PubMed - in process]
Digg this Post!Add Post to del.icio.usBookmark Post in TechnoratiFurl this Post!
Reply With Quote
Reply

  NoBlood > Resources > Medical Articles and Abstracts

« Previous Thread | Next Thread »


Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools
Display Modes Rate This Thread
Linear Mode Linear Mode
Rate This Thread:

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
vB code is On
Smilies are On
[IMG] code is On
HTML code is On
Trackbacks are On
Pingbacks are On
Refbacks are On

Similar Threads
Thread Thread Starter Forum Replies Last Post
Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa dhcatlady Medical Articles and Abstracts 0 06-15-2007 09:22 PM
Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management. Sharon Grant Medical Articles and Abstracts 0 09-26-2006 09:33 PM
A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for Nika Medical Articles and Abstracts 0 04-04-2005 10:23 PM
Revised labeling for epoetin alfa (Procrit, Ortho Biotech) Nika News and Hot Topics such as Hepatitis C, SARS and AIDS 0 03-16-2005 07:37 PM
Preoperative administration of epoetin alfa to reduce transfusion requirements in TJ Jan B. Wade Medical Articles and Abstracts 0 06-11-2003 06:57 AM


All times are GMT -7. The time now is 12:09 AM.
Featured
Hospital Sponsors
Hospitals Directory

Click here to help us make a difference today. Yes, for the price of a cup of coffee, you can help NoBlood continue its mission to advance knowledge and awareness of transfusion alternatives, blood conservation, blood management, bloodless medicine and bloodless surgery.
Please help us continue to make a difference today.

Highlights
Looking for help?
Can you help?

Key Wiki Articles
Note: Click to request permission to edit wiki articles.
Register - FAQ - Members List - Calendar - Files - Videos - Mark Forums Read - NoBlood.org RSS Feeds
NoBlood.org RSS Feeds - Contact Us - NoBlood.org - Archive - Terms of Service - Privacy Statement - Top

Powered by vBulletin® Version 3.6.10
Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
SEO by vBSEO 3.1.0
Copyright © 1996 - 2008, Bloodless Healthcare International, Inc.